Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Deflazacort Formulations
NCT02485431Phase 1Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Jun 2015
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of deflazacort in Duchenne muscular dystrophy (DMD) (5 arms), sponsored by PTC Therapeutics, Inc. Primary endpoint: Pharmacokinetic profile at Day 30. Started Jun 2015; status: completed.
02
Drugs
deflazacort
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT02485431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485431.